Share Price and Basic Stock Data
Last Updated: November 26, 2025, 6:46 pm
| PEG Ratio | -42.97 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Anupam Rasayan India Ltd operates in the specialty chemicals sector, focusing on a diverse range of products. As of its latest reported price of ₹1,179, the company’s market capitalization stood at ₹13,386 Cr. The revenue trajectory shows a robust growth pattern, with sales reported at ₹1,602 Cr for FY 2023, although a decline to ₹1,475 Cr was recorded for FY 2024. In the trailing twelve months (TTM), sales rose to ₹2,108 Cr, indicating a rebound and suggesting recovery from the previous year’s dip. Quarterly sales figures reflect fluctuations, with the latest figure for June 2025 reported at ₹486 Cr, down from ₹500 Cr in March 2025. The overall sales trend highlights the company’s resilience in achieving substantial revenue, albeit with some volatility, which is common in the specialty chemicals industry. The company’s operational efficiency is demonstrated through its operating profit margin (OPM), which stood at 26% in FY 2025, showcasing the ability to maintain profitability amidst fluctuating sales.
Profitability and Efficiency Metrics
Anupam Rasayan’s profitability metrics indicate a mixed performance. The net profit for FY 2023 was reported at ₹223 Cr, reflecting a significant increase from ₹217 Cr in FY 2022. However, the net profit declined to ₹160 Cr in FY 2025, which raises concerns about the sustainability of its profitability. The operating profit margin (OPM) has been relatively stable, reported at 28% for FY 2025, although it dipped from 27% in FY 2023. The interest coverage ratio (ICR) stood at 3.67x, suggesting the company can comfortably meet its interest obligations. However, the return on equity (ROE) at 3.32% and return on capital employed (ROCE) at 7.33% are below average compared to industry standards, indicating potential inefficiencies in capital utilization. The cash conversion cycle (CCC) of 715 days raises concerns about liquidity and operational efficiency, as longer cycles may hinder cash flow and operational agility.
Balance Sheet Strength and Financial Ratios
Analyzing Anupam Rasayan’s balance sheet reveals a relatively stable financial position, with no reported borrowings, which enhances its financial health. The company’s debt-to-equity ratio stands at 0.46, indicating a moderate reliance on debt financing. The working capital days reported at 160 days suggest that the company maintains a reasonable level of liquidity, although the inventory days at 876 indicate potential overstocking or inefficiencies in inventory management. The book value per share is reported at ₹259.28, and the price-to-book value (P/BV) ratio of 2.94x suggests that the stock may be trading at a premium compared to its net asset value. Financial ratios indicate that while the company has a robust asset base, its returns on equity and capital employed need improvement to align better with industry averages. The interest coverage ratio of 3.67x provides some assurance regarding the company’s ability to service its debt.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Anupam Rasayan reflects a significant level of confidence from its promoters, who hold 59.07% of the shares. This level of ownership suggests a strong alignment between management and shareholder interests. Foreign institutional investors (FIIs) hold 7.63% and domestic institutional investors (DIIs) at 1.37%, indicating a moderate interest from institutional investors. The public shareholding has increased to 31.93%, suggesting growing retail investor participation. However, the decline in FII holding from a peak of 10.26% in September 2023 to 7.63% raises concerns about potential volatility in investor sentiment. The reduction in the number of shareholders from 73,326 in December 2022 to 48,785 in September 2025 indicates a consolidation trend, which could reflect either a strategic shift by existing shareholders or a reduction in retail interest. This dynamic may impact liquidity and trading volumes in the stock.
Outlook, Risks, and Final Insight
The outlook for Anupam Rasayan appears cautiously optimistic, primarily due to its strong market position in the specialty chemicals sector and the rebound in sales growth. However, risks remain, including the volatility in quarterly sales and the declining net profit trend, which could affect investor confidence. Additionally, the high cash conversion cycle indicates potential liquidity challenges that may need addressing to ensure operational efficiency. The company’s ability to improve its ROE and ROCE will be critical for enhancing shareholder value. In scenarios where the company can effectively manage its inventory and streamline operations, it may see improved profitability and investor sentiment. Conversely, continued pressure on margins or further declines in net profit could pose significant challenges. Overall, Anupam Rasayan’s performance will hinge on its operational efficiencies and strategic management of financial resources in a competitive market environment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Anupam Rasayan India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 426 Cr. | 46.4 | 86.7/42.6 | 26.5 | 20.5 | 0.86 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 36.1 Cr. | 73.5 | 103/56.0 | 17.3 | 89.6 | 1.36 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 46.2 Cr. | 680 | 988/600 | 21.3 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,676 Cr. | 81.1 | 111/78.0 | 24.3 | 22.0 | 0.62 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 647 Cr. | 260 | 453/241 | 23.2 | 93.8 | 0.96 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,901.36 Cr | 736.42 | 63.11 | 183.02 | 0.42% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 344 | 393 | 392 | 480 | 386 | 392 | 296 | 401 | 254 | 294 | 390 | 500 | 486 |
| Expenses | 245 | 282 | 281 | 363 | 285 | 285 | 216 | 308 | 201 | 214 | 266 | 356 | 362 |
| Operating Profit | 99 | 111 | 111 | 117 | 101 | 107 | 79 | 93 | 53 | 80 | 124 | 144 | 124 |
| OPM % | 29% | 28% | 28% | 24% | 26% | 27% | 27% | 23% | 21% | 27% | 32% | 29% | 26% |
| Other Income | -8 | -10 | -3 | 24 | 12 | 3 | 2 | 12 | 6 | 2 | -4 | 6 | 5 |
| Interest | 12 | 16 | 14 | 20 | 18 | 20 | 25 | 26 | 22 | 27 | 32 | 31 | 36 |
| Depreciation | 16 | 18 | 18 | 19 | 19 | 20 | 20 | 21 | 21 | 22 | 29 | 31 | 31 |
| Profit before tax | 62 | 67 | 75 | 103 | 77 | 71 | 36 | 58 | 16 | 34 | 59 | 88 | 63 |
| Tax % | 32% | 29% | 28% | 29% | 32% | 31% | 28% | 30% | 25% | 10% | 9% | 29% | 23% |
| Net Profit | 42 | 48 | 54 | 73 | 52 | 49 | 26 | 40 | 12 | 31 | 54 | 63 | 48 |
| EPS in Rs | 3.96 | 4.15 | 4.00 | 5.28 | 3.59 | 3.78 | 1.68 | 2.82 | 0.36 | 1.52 | 2.56 | 4.05 | 3.10 |
Last Updated: August 19, 2025, 11:40 pm
Below is a detailed analysis of the quarterly data for Anupam Rasayan India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 486.00 Cr.. The value appears to be declining and may need further review. It has decreased from 500.00 Cr. (Mar 2025) to 486.00 Cr., marking a decrease of 14.00 Cr..
- For Expenses, as of Jun 2025, the value is 362.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 356.00 Cr. (Mar 2025) to 362.00 Cr., marking an increase of 6.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 124.00 Cr.. The value appears to be declining and may need further review. It has decreased from 144.00 Cr. (Mar 2025) to 124.00 Cr., marking a decrease of 20.00 Cr..
- For OPM %, as of Jun 2025, the value is 26.00%. The value appears to be declining and may need further review. It has decreased from 29.00% (Mar 2025) to 26.00%, marking a decrease of 3.00%.
- For Other Income, as of Jun 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 36.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.00 Cr. (Mar 2025) to 36.00 Cr., marking an increase of 5.00 Cr..
- For Depreciation, as of Jun 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 31.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 88.00 Cr. (Mar 2025) to 63.00 Cr., marking a decrease of 25.00 Cr..
- For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Mar 2025) to 23.00%, marking a decrease of 6.00%.
- For Net Profit, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 15.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.10. The value appears to be declining and may need further review. It has decreased from 4.05 (Mar 2025) to 3.10, marking a decrease of 0.95.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:57 am
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 502 | 529 | 811 | 1,074 | 1,602 | 1,475 | 1,437 | 2,108 |
| Expenses | 408 | 394 | 617 | 769 | 1,171 | 1,094 | 1,036 | 1,579 |
| Operating Profit | 93 | 135 | 194 | 305 | 431 | 381 | 401 | 529 |
| OPM % | 19% | 25% | 24% | 28% | 27% | 26% | 28% | 25% |
| Other Income | 19 | 11 | 26 | 8 | 10 | 30 | 11 | 15 |
| Interest | 24 | 45 | 69 | 31 | 63 | 89 | 112 | 135 |
| Depreciation | 23 | 29 | 52 | 60 | 71 | 80 | 102 | 123 |
| Profit before tax | 66 | 72 | 100 | 222 | 308 | 242 | 198 | 286 |
| Tax % | 24% | 26% | 30% | 31% | 30% | 31% | 19% | |
| Net Profit | 49 | 53 | 70 | 152 | 217 | 167 | 160 | 223 |
| EPS in Rs | 9.85 | 10.64 | 7.04 | 15.18 | 16.84 | 11.72 | 8.49 | 13.61 |
| Dividend Payout % | -0% | -0% | 7% | 7% | 15% | 11% | 9% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 8.16% | 32.08% | 117.14% | 42.76% | -23.04% | -4.19% |
| Change in YoY Net Profit Growth (%) | 0.00% | 23.91% | 85.07% | -74.38% | -65.80% | 18.85% |
Anupam Rasayan India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 10% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | -15% |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 13% |
| 1 Year: | 44% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 5% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:21 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 88 | 89 | 92 | 95 | 95 | 143 | 186 |
| Inventory Days | 277 | 515 | 530 | 852 | 483 | 627 | 876 |
| Days Payable | 105 | 226 | 215 | 225 | 167 | 247 | 348 |
| Cash Conversion Cycle | 260 | 379 | 408 | 722 | 410 | 524 | 715 |
| Working Capital Days | 56 | 21 | 168 | 218 | 153 | 138 | 160 |
| ROCE % | 9% | 10% | 11% | 13% | 9% | 7% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Quant Small Cap Fund | 2,086,516 | 1.26 | 198.07 | 2,086,516 | 2025-04-22 17:25:14 | 0% |
| Aditya Birla Sun Life Pure Value Fund | 321,844 | 0.54 | 30.55 | 321,844 | 2025-04-22 17:25:14 | 0% |
| Nippon India Nifty Smallcap 250 Index Fund | 16,067 | 0.14 | 1.53 | 16,067 | 2025-04-22 17:25:14 | 0% |
| Axis Nifty Smallcap 50 Index Fund | 11,015 | 0.43 | 1.05 | 11,015 | 2025-04-22 17:25:14 | 0% |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 9,823 | 0.14 | 0.93 | 9,823 | 2025-04-22 17:25:14 | 0% |
| Aditya Birla Sun Life Nifty Smallcap 50 Index Fund | 8,754 | 0.44 | 0.83 | 8,754 | 2025-04-22 17:25:14 | 0% |
| SBI Nifty Smallcap 250 Index Fund | 8,158 | 0.14 | 0.77 | 8,158 | 2025-04-22 17:25:14 | 0% |
| ICICI Prudential Nifty Smallcap 250 Index Fund | 3,725 | 0.14 | 0.35 | 3,725 | 2025-04-22 17:25:14 | 0% |
| Motilal Oswal Nifty 500 Index Fund | 972 | 0.01 | 0.09 | 972 | 2025-04-22 17:25:14 | 0% |
| Edelweiss Nifty Smallcap 250 Index Fund | 442 | 0.14 | 0.04 | 442 | 2025-04-22 17:25:14 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 8.50 | 15.48 | 20.91 | 15.22 | 8.56 |
| Diluted EPS (Rs.) | 8.50 | 15.46 | 20.86 | 15.18 | 8.56 |
| Cash EPS (Rs.) | 23.86 | 22.51 | 26.66 | 21.11 | 12.20 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 259.28 | 251.49 | 233.38 | 172.26 | 157.46 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 259.28 | 251.49 | 233.38 | 172.26 | 157.46 |
| Revenue From Operations / Share (Rs.) | 130.72 | 134.36 | 149.06 | 106.34 | 81.15 |
| PBDIT / Share (Rs.) | 37.51 | 37.43 | 40.94 | 31.14 | 22.04 |
| PBIT / Share (Rs.) | 28.20 | 30.17 | 34.32 | 25.14 | 16.87 |
| PBT / Share (Rs.) | 18.00 | 22.02 | 28.49 | 22.07 | 10.01 |
| Net Profit / Share (Rs.) | 14.55 | 15.25 | 20.04 | 15.12 | 7.04 |
| NP After MI And SOA / Share (Rs.) | 8.49 | 11.71 | 16.83 | 15.18 | 7.04 |
| PBDIT Margin (%) | 28.69 | 27.85 | 27.46 | 29.28 | 27.15 |
| PBIT Margin (%) | 21.57 | 22.45 | 23.02 | 23.64 | 20.78 |
| PBT Margin (%) | 13.76 | 16.39 | 19.11 | 20.75 | 12.33 |
| Net Profit Margin (%) | 11.13 | 11.35 | 13.44 | 14.21 | 8.66 |
| NP After MI And SOA Margin (%) | 6.49 | 8.71 | 11.28 | 14.27 | 8.66 |
| Return on Networth / Equity (%) | 3.27 | 4.65 | 7.62 | 8.81 | 4.46 |
| Return on Capital Employeed (%) | 8.95 | 10.07 | 12.43 | 10.97 | 8.97 |
| Return On Assets (%) | 1.77 | 2.79 | 4.78 | 5.26 | 3.05 |
| Long Term Debt / Equity (X) | 0.06 | 0.07 | 0.14 | 0.28 | 0.15 |
| Total Debt / Equity (X) | 0.46 | 0.36 | 0.33 | 0.46 | 0.24 |
| Asset Turnover Ratio (%) | 0.29 | 0.35 | 0.48 | 0.41 | 0.40 |
| Current Ratio (X) | 1.42 | 1.69 | 2.60 | 2.43 | 2.59 |
| Quick Ratio (X) | 0.62 | 0.89 | 1.46 | 0.98 | 1.42 |
| Inventory Turnover Ratio (X) | 0.74 | 0.69 | 0.85 | 1.02 | 1.19 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 16.71 | 5.78 | 3.28 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 10.32 | 4.15 | 2.35 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 83.29 | 94.22 | 96.72 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 89.68 | 95.85 | 97.65 | 0.00 |
| Interest Coverage Ratio (X) | 3.67 | 4.59 | 7.02 | 10.13 | 3.21 |
| Interest Coverage Ratio (Post Tax) (X) | 2.43 | 2.87 | 4.44 | 5.92 | 2.03 |
| Enterprise Value (Cr.) | 9804.24 | 10438.77 | 9646.44 | 8830.95 | 4991.83 |
| EV / Net Operating Revenue (X) | 6.82 | 7.08 | 6.02 | 8.28 | 6.16 |
| EV / EBITDA (X) | 23.78 | 25.40 | 21.93 | 28.29 | 22.67 |
| MarketCap / Net Operating Revenue (X) | 5.83 | 6.47 | 5.80 | 7.73 | 6.04 |
| Retention Ratios (%) | 0.00 | 83.28 | 94.21 | 96.71 | 0.00 |
| Price / BV (X) | 2.94 | 3.45 | 3.91 | 4.77 | 3.11 |
| Price / Net Operating Revenue (X) | 5.83 | 6.47 | 5.80 | 7.73 | 6.04 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Anupam Rasayan India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has decreased from 15.48 (Mar 24) to 8.50, marking a decrease of 6.98.
- For Diluted EPS (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has decreased from 15.46 (Mar 24) to 8.50, marking a decrease of 6.96.
- For Cash EPS (Rs.), as of Mar 25, the value is 23.86. This value is within the healthy range. It has increased from 22.51 (Mar 24) to 23.86, marking an increase of 1.35.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 259.28. It has increased from 251.49 (Mar 24) to 259.28, marking an increase of 7.79.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 259.28. It has increased from 251.49 (Mar 24) to 259.28, marking an increase of 7.79.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 130.72. It has decreased from 134.36 (Mar 24) to 130.72, marking a decrease of 3.64.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 37.51. This value is within the healthy range. It has increased from 37.43 (Mar 24) to 37.51, marking an increase of 0.08.
- For PBIT / Share (Rs.), as of Mar 25, the value is 28.20. This value is within the healthy range. It has decreased from 30.17 (Mar 24) to 28.20, marking a decrease of 1.97.
- For PBT / Share (Rs.), as of Mar 25, the value is 18.00. This value is within the healthy range. It has decreased from 22.02 (Mar 24) to 18.00, marking a decrease of 4.02.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 15.25 (Mar 24) to 14.55, marking a decrease of 0.70.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.49. This value is within the healthy range. It has decreased from 11.71 (Mar 24) to 8.49, marking a decrease of 3.22.
- For PBDIT Margin (%), as of Mar 25, the value is 28.69. This value is within the healthy range. It has increased from 27.85 (Mar 24) to 28.69, marking an increase of 0.84.
- For PBIT Margin (%), as of Mar 25, the value is 21.57. This value exceeds the healthy maximum of 20. It has decreased from 22.45 (Mar 24) to 21.57, marking a decrease of 0.88.
- For PBT Margin (%), as of Mar 25, the value is 13.76. This value is within the healthy range. It has decreased from 16.39 (Mar 24) to 13.76, marking a decrease of 2.63.
- For Net Profit Margin (%), as of Mar 25, the value is 11.13. This value exceeds the healthy maximum of 10. It has decreased from 11.35 (Mar 24) to 11.13, marking a decrease of 0.22.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.49. This value is below the healthy minimum of 8. It has decreased from 8.71 (Mar 24) to 6.49, marking a decrease of 2.22.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.27. This value is below the healthy minimum of 15. It has decreased from 4.65 (Mar 24) to 3.27, marking a decrease of 1.38.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.95. This value is below the healthy minimum of 10. It has decreased from 10.07 (Mar 24) to 8.95, marking a decrease of 1.12.
- For Return On Assets (%), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 5. It has decreased from 2.79 (Mar 24) to 1.77, marking a decrease of 1.02.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.07 (Mar 24) to 0.06, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has increased from 0.36 (Mar 24) to 0.46, marking an increase of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.29. It has decreased from 0.35 (Mar 24) to 0.29, marking a decrease of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 1.5. It has decreased from 1.69 (Mar 24) to 1.42, marking a decrease of 0.27.
- For Quick Ratio (X), as of Mar 25, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.89 (Mar 24) to 0.62, marking a decrease of 0.27.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 4. It has increased from 0.69 (Mar 24) to 0.74, marking an increase of 0.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 16.71 (Mar 24) to 0.00, marking a decrease of 16.71.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.32 (Mar 24) to 0.00, marking a decrease of 10.32.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 83.29 (Mar 24) to 0.00, marking a decrease of 83.29.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.68 (Mar 24) to 0.00, marking a decrease of 89.68.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.67. This value is within the healthy range. It has decreased from 4.59 (Mar 24) to 3.67, marking a decrease of 0.92.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 3. It has decreased from 2.87 (Mar 24) to 2.43, marking a decrease of 0.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 9,804.24. It has decreased from 10,438.77 (Mar 24) to 9,804.24, marking a decrease of 634.53.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.82. This value exceeds the healthy maximum of 3. It has decreased from 7.08 (Mar 24) to 6.82, marking a decrease of 0.26.
- For EV / EBITDA (X), as of Mar 25, the value is 23.78. This value exceeds the healthy maximum of 15. It has decreased from 25.40 (Mar 24) to 23.78, marking a decrease of 1.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.83. This value exceeds the healthy maximum of 3. It has decreased from 6.47 (Mar 24) to 5.83, marking a decrease of 0.64.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 83.28 (Mar 24) to 0.00, marking a decrease of 83.28.
- For Price / BV (X), as of Mar 25, the value is 2.94. This value is within the healthy range. It has decreased from 3.45 (Mar 24) to 2.94, marking a decrease of 0.51.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.83. This value exceeds the healthy maximum of 3. It has decreased from 6.47 (Mar 24) to 5.83, marking a decrease of 0.64.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Anupam Rasayan India Ltd:
- Net Profit Margin: 11.13%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.95% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.27% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.43
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 92.8 (Industry average Stock P/E: 63.11)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.46
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.13%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | 1101 to 1107, 11th Floor, Icon Rio, Behind Icon Business Centre, Surat Gujarat 395007 | investors@anupamrasayan.com http://www.anupamrasayan.com |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Kiran C Patel | Chairman & Non-Exe.Director |
| Mrs. Mona A Desai | Vice Chairman & Whole Time Dir |
| Mr. Anand S Desai | Managing Director |
| Dr. Anuj Hemantbhai Thakar | Whole Time Director |
| Dr. Namrata Dharmendra Jariwala | Independent Director |
| Mr. Vijay Kumar Batra | Independent Director |
| Mr. Vinesh Prabhakar Sadekar | Independent Director |
| Mr. Hetul Krishnakant Mehta | Independent Director |